Motility News

LAS VEGAS — In this exclusive video, Nicholas J. Talley, MD, PhD, professor of medicine and pro vice-chancellor of global research at the University of Newcastle, Australia, discusses the David Sun Lecture, which he delivered at ACG 2016. This distinguished lecture focused on new developments in functional gut disorders.

LAS VEGAS — Naldemedine induced spontaneous bowel movements more quickly than placebo — often within 4 hours of first dose — and maintained its efficacy for 12 weeks, according to data presented at ACG 2016.

LAS VEGAS — In this exclusive video from ACG 2016, John R. Saltzman, MD, FACG, director of endoscopy at Brigham and Women’s Hospital, professor of medicine at Harvard Medical School, and Chair of Educational Affairs for ACG, discusses several presentations delivered at the presidential plenary session.

LAS VEGAS — Oral Emend improved gastroparesis symptoms based on commonly used gastroparesis measures in a randomized controlled trial, according to the APRON results presented at ACG 2016.

Researchers showed superiority of Amitiza over placebo for improving abdominal pain, bloating and composite endpoints including stool frequency in patients with constipation-predominant irritable bowel syndrome, according to post hoc analyses of two pivotal phase 3 randomized controlled trials.

A spike in intussusception hospitalization rates occurred in children aged 8 to 11 weeks after children received initial doses of RotaTeq or Rotarix vaccine for rotavirus compared with prevaccine years, according to recent study results.

Treatment with and response to methylnaltrexone for opioid-induced constipation appeared associated with improved OS in patients with advanced cancers, according to a post-hoc analysis of two randomized trials.

In children and adolescents, migraine headaches are positively associated with functional dyspepsia, irritable bowel syndrome and abdominal migraine, and negatively associated with functional constipation, investigators from a European case-control study found.

Electroacupuncture increased complete spontaneous bowel movements within 8 weeks, according to findings published in the Annals of Internal Medicine.

Naldemedine was safe and well tolerated through 52 weeks for treating opioid-induced constipation in patients with chronic noncancer pain, according to research presented at PAINWeek 2016.